SCHEMBL4309100

SCHEMBL4309100

CC(=O)N[C@@H]1[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](CO)O[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LGALS3 P17931 7/20 0.66
LGALS8 O00214 2/20 0.66
LGALS4 P56470 2/20 0.66
MAPK1 P28482 2/20 0.56
CD69 Q07108 1/20 0.52
ALDH1A1 P00352 1/20 0.51
THRB P10828 1/20 0.51
CHIA Q9BZP6 1/20 0.51
LGALS1 P09382 1/20 0.50
LGALS7; LGALS7B P47929 1/20 0.50
LGALS9 O00182 1/20 0.48
AMY2A P04746 2/20 0.47
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29466466 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL10524839 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL30055416 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL117333 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL4125477 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL9398176 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL17050874 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL14268473 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL20555908 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL29938306 1.00 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 US disclosed
US-20150309021-A1 Advanced Drug Development and Manufacturing LOS ALAMOS NATIONAL SECURITY, LLC 2015-10-29 US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 EP disclosed
EP-2084519-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING Los Alamos National Security, LLC (US) 2009-08-05 EP disclosed
WO-2008127291-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING LOS ALAMOS NATIONAL SECURITY, LLC (US) 2008-10-23 WO disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 US disclosed